Ebun Garner
Patrimonio netto: 367 614 $ in data 30/09/2026
Patrimonio netto: 367 614 $ in data 30/09/2026
Mr. Ebun S.
Garner is a Chief Legal Officer at Erasca, Inc. Mr. Garner was previously employed as an Assistant General Counsel by ACADIA Pharmaceuticals, Inc., a Secretary & Chief Legal Officer by Imbria Pharmaceuticals, Inc., an Associate General Counsel by Neurocrine Biosciences, Inc., a Secretary, Senior Vice President & General Counsel by Alphatec Holdings, Inc., a Secretary, Senior Vice President & General Counsel by Alphatec Spine, Inc., an Associate by Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC, an Associate by Squadron, Ellenoff, Plesent & Sheinfeld LLP, and a Director General by Scient'x SA. He received his undergraduate degree from the University of Pennsylvania and a graduate degree from New York University School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ERASCA, INC. 0,01% | 01/04/2026 | 25.076 ( 0,01% ) | 367 614 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ERASCA, INC. | Consigliere Generale | 01/04/2021 |
| Società | Posizione | Fine |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/04/2021 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Consigliere Generale | 01/07/2020 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/04/2019 |
| ALPHATEC HOLDINGS, INC. | Contatto Relazioni con gli Investitori | 23/07/2012 |
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | Consigliere Generale | 28/02/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Alphatec Holdings, Inc.
Alphatec Holdings, Inc. Medical SpecialtiesHealth Technology Operates as a holding company with interests in medical equipment and supplies | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Squadron, Ellenoff, Plesent & Sheinfeld LLP
Squadron, Ellenoff, Plesent & Sheinfeld LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Scient'x SA
Scient'x SA Medical SpecialtiesHealth Technology Designs, develops and markets spinal implant devices for the lumbar, thoracic and cervical spine | Health Technology |
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and sells medical devices for surgical treatment of spine disorders | Health Technology |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale